The coronavirus vaccine has been shown to be safe, but some of the temporary side effects can feel pretty rough especially when you get that second dose. Iahn Gonsenhauser, chief patient safety officer at the Ohio State University Wexner Medical Center, described his own experience with “extreme” fever and chills after his second shot so you know what to expect.
The coronavirus vaccine has been shown to be safe, but some of the temporary side effects can feel pretty rough especially when you get that second dose. Iahn Gonsenhauser, chief patient safety officer at the Ohio State University Wexner Medical Center, described his own experience with “extreme” fever and chills after his second shot so you know what to expect.
Changed sleep habits
Recognizing the signs of burnout is the first step to addressing it, says Steginus.
That s important, because studies point to significant health concerns if burnout isn’t addressed. For example, some research has found that burnout can considerably increase the risk of cardiovascular problems, including high blood pressure. A study published in October 2017 in
PLoS One found links between burnout and gastrointestinal issues, prolonged fatigue, higher pain levels, respiratory problems, insomnia, musculoskeletal pain, and even a shorter life span.
As Steginus notes, burnout doesn t just affect you, either. The old adage “You can’t pour from an empty cup” applies here if you’re completely depleted, it makes it much harder, if not impossible, to take care of those around you. “Burnout has a ripple effect,” she says.
AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy Clinical team led by neurological gene therapy expert, Dr. Krystof Bankiewicz, joins AskBio
January 28, 2021 09:20 ET | Source: Asklepios BioPharmaceutical, Inc. Asklepios BioPharmaceutical, Inc. Research Triangle Park, North Carolina, UNITED STATES
RESEARCH TRIANGLE PARK, N.C., Jan. 28, 2021 (GLOBE NEWSWIRE) Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned subsidiary of Bayer AG, today announced that the clinical team from Brain Neurotherapy Bio, Inc., a gene therapy company based in Columbus, Ohio, has joined AskBio to expand its clinical pipeline for the treatment of neurodegenerative disorders. Brain Neurotherapy Bio (BNB) was established in 2018 by Krystof Bankiewicz, MD, PhD, in association with AskBio founders Sheila Mikhail, JD, and Jude
New compound could lead to a new class of diabetes drugs
Research led by The Ohio State University Wexner Medical Center and College of Medicine identified a new compound that might serve as a basis for developing a new class of drugs for diabetes.
Study findings are published online in the journal
Nature Chemical Biology.
The adenosine monophosphate-activated protein kinase (Ampk) is a crucial enzyme involved in sensing the body s energy stores in cells. Impaired energy metabolism is seen in obesity, which is a risk factor for diabetes. Some medications used to treat diabetes, such as metformin, work by increasing the activity of Ampk.